Anna Himes, NP
Family · Greenwood, INNPI 1154930626
Payments from drug & device makers
Across 24 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$52
- Astellas Pharma US Inc$52
- AstraZeneca$50
- AbbVie$44
- Corium, LLC$33
- Novo Nordisk$29
- plus $142 from 8 others
What the payments were for
- Food & beverage$402100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $52 |
| Astellas Pharma US Inc | 2 | $52 |
| AstraZeneca | 3 | $50 |
| AbbVie | 3 | $44 |
| Corium, LLC | 3 | $33 |
| Novo Nordisk | 2 | $29 |
| Neurocrine Biosciences, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Amgen | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $11 |
How this compares
$402 in reported general payments places this provider in the 50th percentile of 4,392 family providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PaxlovidNirmatrelvir/Ritonavir | 20 | $1,400 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 47 | $575 |
| Azithromycin | 103 | $486 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $484 |
| Cephalexin | 43 | $292 |
| Methylprednisolone | 52 | $272 |
| Ondansetron OdtOndansetron | 16 | $237 |
| Amoxicillin | 55 | $175 |
| Doxycycline Monohydrate | 20 | $151 |
| Fluconazole | 24 | $104 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $103 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 31 | $90 |
| Fluticasone Propionate | 12 | $60 |
| Prednisone | 19 | $36 |
Paid to pharmacies, not to this prescriber.
Other family in Greenwood
- Lauren WheatGreenwood$14K
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.